,
DAY ONE:
AGENDA (subject to change)
SESSION 1 – Regulations: aircrew and passengers
09.00UPPER AGE LIMIT: ICAO REVIEW OF THE RESTRICTIONS
Dr. Anthony Evans, Chief, Aviation Medicine Section, ICAO

POWERPOINT: Anthony Evans, ICAO
09.30UPDATE ON EASA ACTIVITIES IN THE MEDICAL FIELD
Dr. Annette Ruge, Chief Medical Officer, EASA

POWERPOINT: Annette Ruge, EASA
10.00MED EXPRESS: A NEW WAY OF DOING BUSINESS
Dr. Robert Johnson, CAMI Deputy Director, FAA, USA

POWERPOINT: Robert Johnson, FAA
11.00AIRCRAFT DISINSECTION – WHO RECOMMENDATIONS’
Dr Richard Brown, WHO

POWERPOINT:Richard Brown, WHO
11.30Disinsection - What is new with the air curtain?
Dr. Jerome Hogsette, USDA

POWERPOINT: Jerome Hogsette, USDA
SESSION 2 – Cabin Air Quality
13.00EVIDENCE AND THE ETHICS OF REGULATION: WHAT DOES THE EXPERT PANEL ON AIRCRAFT AIR QUALITY (EPAAQ) ADD TO OUR KNOWLEDGE
Dr. Pooshan Navathe, Principal Medical Officer,CASA, Australia

POWERPOINT: Dr Navathe, CASA
13.30US AIRWAYS EXPERIENCE WITH FUME EVENTS
Paul Morell, VP, Safety & Regulatory Compliance, US Airways

POWERPOINT: Paul Morrell, US Airways
14.00BLEED AIR CONTAMINATION INVESTIGATION: WHAT IS THE PLACE OF BIOMARKERS?
Dr.Clement Furlong, University of Washington

POWERPOINT TO FOLLOW: Clement Furlong, University of Washington
14.30What the science says about chemicals, bleed air and health effects
Dr Richard Pleus, Intertox

POWERPOINT:Richard Pleus, Intertox
15.30FUME EVENTS: REPORT OF THE BRE WORKSHOP
Prof. Michael Bagshaw, Associate Consultant, BRE, UK

POWERPOINT: Michael Bagshaw, BRE
16.00Cabin Air Filtration Systems - Novel Technological Solutions for Commercial Aircraft
Dr. Robert Johnson, CAMI Deputy Director, FAA, USA

POWERPOINT: Robert Johnson, FAA
16.30Bleed Air Contamination Limits: An SAE standard project
Richard Fox PhD, Honeywell Aerospace

POWERPOINT: Richard Fox, Honeywell
16.30Cabin Air Filtration Systems - Novel Technological Solutions for Commercial Aircraft
Karen Bull, Pall Corporation

POWERPOINT: Karen Bull, Pall Corporation
DAY TWO
SESSION 3 - Aircrew and Passenger Health
09.00THE MOUSE THAT ROARED! A CASE OF THE SNIFFLES…”
Dr. Tim Sprott, Medical Director, Air New Zealand

POWERPOINT: Tim Sprott, Air NZ
09.30ACTIVE PREFLIGHT MEDICAL SCREENING WITHIN KOREAN AIR
Dr. SanJe Cho, Korean Air AME

POWERPOINT: San Je Cho, Korean Air
10.00Managing Chestpain In-Flight: What, Why and How?
Dr. Paulo M. Alves, Vice President of Aviation and Maritime Health, MedAire
Dr Nomy Ahmed, Medical Officer, Emirates Airlines

POWERPOINT: Paulo Alves, Nomy Ahmed
11.00PRMs: Why are Airlines getting such bad press
Dr Willem A. Godefroy, PassePartout Training

Willelm Godefroy, Passepartout Training
11.30TRAINING CABIN CREW ON HEALTH PROTECTION AND MEDICAL ISSUES
Dr. David Powell, Medical Officer, Air New Zealand, Otago University

POWERPOINT: David Powell, Air NZ
SESSION 4 – AIRCREW HEALTH
13.00INSULIN TREATED DIABETES AND CONTINUOUS GLUCOSE MONITORING: DOES IT HAVE A PLACE IN THE COCKPIT
Dr. Tim Sprott, Medical Director, Air New Zealand

POWERPOINT: Tim Sprott, Air NZ
13.30A CASE OF ANTI-PHOSPHOLIP SYNDROME IN A CABIN CREW
Rose Ong, Chief Medical Officer, Cathay Pacific Airways

POWERPOINT: Rose Ong, Cathay Pacific
14.00MANAGEMENT OF ALCOHOL ABUSE IN CABIN CREW: A CASE REVIEW
Dr Christine de Vries, Medical Officer, KLM Health Services

POWERPOINT, Christine de Vries
14.30FLIGHT CREW INTOXICATED AT THE AIRPORT: CIVIL AVIATION AUTHORITY’S RESPONSE
Dr. David Salisbury, Director Medicine, Transport Canada

POWERPOINT, David Salisbury, Transport Canada
15.30DRUG AND ALCOHOL PROGRAMME: ONE AIRLINE EXPERIENCE
Dr. Fiona Rennie, Vice President Medical Services, Emirates Airline

POWERPOINT, Fiona Rennie, Emirates,
16.00DRUG TESTING: ADVANTAGES AND DISADVANTAGES OF THE DIFFERENT METHODS
Michael Mikalakis, Team Leader, LGC Forensics

POWERPOINT: Lianne Gray, LGC Forensics

Sponsorship & Exhibition Opportunities